Versigent PLC (VGNT) director receives grant of 5,168 Ordinary Shares

Rhea-AI Filing Summary

Versigent PLC director Tamez Armando received a share grant reported on Form 4. He was awarded 5,168 Ordinary Shares on April 22, 2026 at a stated price of $0.00 per share, indicating a compensation-related grant rather than an open-market purchase.

After this award, his directly held ownership stands at 5,168 Ordinary Shares. The filing does not show any sales or derivative option exercises, only this single grant/award acquisition transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Tamez Armando

Role null

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	5,168	$0.00	--

Holdings After Transaction: Ordinary Shares — 5,168 shares (Direct, null)

Footnotes (1)

Key Figures

Share grant: 5,168 shares Grant price per share: $0.00 per share Shares held after grant: 5,168 shares +1 more

4 metrics

Share grant 5,168 shares Ordinary Shares granted on April 22, 2026

Grant price per share $0.00 per share Stated transaction price for awarded shares

Shares held after grant 5,168 shares Total directly held Ordinary Shares post-transaction

Acquire transactions 1 transaction Form 4 transaction summary for this filing

Key Terms

Form 4, Ordinary Shares, grant or award acquisition

3 terms

Form 4 regulatory

"Versigent PLC director Tamez Armando received a share grant reported on Form 4."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Ordinary Shares financial

"He was awarded 5,168 Ordinary Shares on April 22, 2026"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

grant or award acquisition financial

"It reports a single grant of 5,168 Ordinary Shares, classified as a grant or award acquisition"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tamez Armando

(Last) (First) (Middle)

SPITALSTRASSE 5,

(Street)

SCHAFFHAUSEN SWITZERLAND 8200

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Versigent PLC [ VGNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	04/22/2026		A		5,168	A	$0.00	5,168	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Janis Acosta, Attorney-in-fact for Armando Tamez	04/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Versigent PLC (VGNT) report for Tamez Armando?

Versigent PLC reported that director Tamez Armando received a grant of 5,168 Ordinary Shares. The award was recorded at a price of $0.00 per share, indicating a compensation-related transaction rather than an open-market purchase or sale of existing shares.

How many Versigent PLC (VGNT) shares does Tamez Armando hold after this Form 4?

After the reported transaction, Tamez Armando directly holds 5,168 Ordinary Shares of Versigent PLC. The Form 4 shows this post-transaction balance, with no additional derivative positions disclosed in the filing’s derivative summary section for further equity exposure.

Was the Versigent PLC (VGNT) Form 4 a stock purchase or a grant?

The Versigent PLC Form 4 shows a grant or award acquisition for Tamez Armando, not an open-market purchase. The transaction code is “A” and the price per share is listed as $0.00, which is typical for equity awards granted as part of director compensation.

Did Tamez Armando sell any Versigent PLC (VGNT) shares in this Form 4?

No, the Form 4 shows no sales of Versigent PLC shares by Tamez Armando. It reports a single grant of 5,168 Ordinary Shares, classified as a grant or award acquisition, with no accompanying sale or disposition transactions disclosed in this filing.

Does the Versigent PLC (VGNT) Form 4 include any stock options or derivatives?

The Form 4 derivative summary for Versigent PLC lists no derivative positions for Tamez Armando. It only discloses a non-derivative grant of 5,168 Ordinary Shares, so there are no reported options, warrants, or other derivative securities associated with this specific filing.